5-[4-[2-[4-[[4-[6-(azetidin-1-yl)-2-methyl-1-oxo-2,7-naphthyridin-4-yl]-2,6-dimethoxyphenyl]methyl]-3-(methoxymethyl)piperazin-1-yl]ethyl]piperidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione

C47H56N8O8 — CID 167395312

IUPAC5-[4-[2-[4-[[4-[6-(azetidin-1-yl)-2-methyl-1-oxo-2,7-naphthyridin-4-yl]-2,6-dimethoxyphenyl]methyl]-3-(methoxymethyl)piperazin-1-yl]ethyl]piperidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
SMILESCOCC1CN(CCC2CCN(c3ccc4c(c3)C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)CCN1Cc1c(OC)cc(-c2cn(C)c(=O)c3cnc(N4CCC4)cc23)cc1OC
InChIInChI=1S/C47H56N8O8/c1-50-26-37(34-23-42(53-13-5-14-53)48-24-36(34)45(50)58)30-20-40(62-3)38(41(21-30)63-4)27-54-19-18-51(25-32(54)28-61-2)15-10-29-11-16-52(17-12-29)31-6-7-33-35(22-31)47(60)55(46(33)59)39-8-9-43(56)49-44(39)57/h6-7,20-24,26,29,32,39H,5,8-19,25,27-28H2,1-4H3,(H,49,56,57)
InChIKeyZXTRJAAUIIHDSV-UHFFFAOYSA-N
MW861.01 g/mol
LogP3.67
Rot. Bonds13

About 5-[4-[2-[4-[[4-[6-(azetidin-1-yl)-2-methyl-1-oxo-2,7-naphthyridin-4-yl]-2,6-dimethoxyphenyl]methyl]-3-(methoxymethyl)piperazin-1-yl]ethyl]piperidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione

5-[4-[2-[4-[[4-[6-(azetidin-1-yl)-2-methyl-1-oxo-2,7-naphthyridin-4-yl]-2,6-dimethoxyphenyl]methyl]-3-(methoxymethyl)piperazin-1-yl]ethyl]piperidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione (PubChem CID 167395312) has the molecular formula C47H56N8O8 and a molecular weight of 861.01 g/mol. Its IUPAC name is 5-[4-[2-[4-[[4-[6-(azetidin-1-yl)-2-methyl-1-oxo-2,7-naphthyridin-4-yl]-2,6-dimethoxyphenyl]methyl]-3-(methoxymethyl)piperazin-1-yl]ethyl]piperidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione.

Molecular Properties

Compound Name5-[4-[2-[4-[[4-[6-(azetidin-1-yl)-2-methyl-1-oxo-2,7-naphthyridin-4-yl]-2,6-dimethoxyphenyl]methyl]-3-(methoxymethyl)piperazin-1-yl]ethyl]piperidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
PubChem CID167395312
Molecular FormulaC47H56N8O8
Molecular Weight861.01 g/mol
Exact Mass860.42
IUPAC Name5-[4-[2-[4-[[4-[6-(azetidin-1-yl)-2-methyl-1-oxo-2,7-naphthyridin-4-yl]-2,6-dimethoxyphenyl]methyl]-3-(methoxymethyl)piperazin-1-yl]ethyl]piperidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione
SMILESCOCC1CN(CCC2CCN(c3ccc4c(c3)C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)CCN1Cc1c(OC)cc(-c2cn(C)c(=O)c3cnc(N4CCC4)cc23)cc1OC
InChIInChI=1S/C47H56N8O8/c1-50-26-37(34-23-42(53-13-5-14-53)48-24-36(34)45(50)58)30-20-40(62-3)38(41(21-30)63-4)27-54-19-18-51(25-32(54)28-61-2)15-10-29-11-16-52(17-12-29)31-6-7-33-35(22-31)47(60)55(46(33)59)39-8-9-43(56)49-44(39)57/h6-7,20-24,26,29,32,39H,5,8-19,25,27-28H2,1-4H3,(H,49,56,57)
InChIKeyZXTRJAAUIIHDSV-UHFFFAOYSA-N
XLogP3.67
TPSA159.09 Ų
H-Bond Donors1
H-Bond Acceptors14
Rotatable Bonds13
Heavy Atoms63
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500861.01
LogP ≤ 53.67
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phthalimide', 'substructure': 'N/A'}

Analyze 5-[4-[2-[4-[[4-[6-(azetidin-1-yl)-2-methyl-1-oxo-2,7-naphthyridin-4-yl]-2,6-dimethoxyphenyl]methyl]-3-(methoxymethyl)piperazin-1-yl]ethyl]piperidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 5-[4-[2-[4-[[4-[6-(azetidin-1-yl)-2-methyl-1-oxo-2,7-naphthyridin-4-yl]-2,6-dimethoxyphenyl]methyl]-3-(methoxymethyl)piperazin-1-yl]ethyl]piperidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione?
The IUPAC name of 5-[4-[2-[4-[[4-[6-(azetidin-1-yl)-2-methyl-1-oxo-2,7-naphthyridin-4-yl]-2,6-dimethoxyphenyl]methyl]-3-(methoxymethyl)piperazin-1-yl]ethyl]piperidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione (CID 167395312) is 5-[4-[2-[4-[[4-[6-(azetidin-1-yl)-2-methyl-1-oxo-2,7-naphthyridin-4-yl]-2,6-dimethoxyphenyl]methyl]-3-(methoxymethyl)piperazin-1-yl]ethyl]piperidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione.
What is the SMILES notation for 5-[4-[2-[4-[[4-[6-(azetidin-1-yl)-2-methyl-1-oxo-2,7-naphthyridin-4-yl]-2,6-dimethoxyphenyl]methyl]-3-(methoxymethyl)piperazin-1-yl]ethyl]piperidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione?
The canonical SMILES for 5-[4-[2-[4-[[4-[6-(azetidin-1-yl)-2-methyl-1-oxo-2,7-naphthyridin-4-yl]-2,6-dimethoxyphenyl]methyl]-3-(methoxymethyl)piperazin-1-yl]ethyl]piperidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione is COCC1CN(CCC2CCN(c3ccc4c(c3)C(=O)N(C3CCC(=O)NC3=O)C4=O)CC2)CCN1Cc1c(OC)cc(-c2cn(C)c(=O)c3cnc(N4CCC4)cc23)cc1OC.
What is the InChIKey of 5-[4-[2-[4-[[4-[6-(azetidin-1-yl)-2-methyl-1-oxo-2,7-naphthyridin-4-yl]-2,6-dimethoxyphenyl]methyl]-3-(methoxymethyl)piperazin-1-yl]ethyl]piperidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione?
The InChIKey is ZXTRJAAUIIHDSV-UHFFFAOYSA-N. The full InChI is InChI=1S/C47H56N8O8/c1-50-26-37(34-23-42(53-13-5-14-53)48-24-36(34)45(50)58)30-20-40(62-3)38(41(21-30)63-4)27-54-19-18-51(25-32(54)28-61-2)15-10-29-11-16-52(17-12-29)31-6-7-33-35(22-31)47(60)55(46(33)59)39-8-9-43(56)49-44(39)57/h6-7,20-24,26,29,32,39H,5,8-19,25,27-28H2,1-4H3,(H,49,56,57).
What are the key properties of 5-[4-[2-[4-[[4-[6-(azetidin-1-yl)-2-methyl-1-oxo-2,7-naphthyridin-4-yl]-2,6-dimethoxyphenyl]methyl]-3-(methoxymethyl)piperazin-1-yl]ethyl]piperidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione?
5-[4-[2-[4-[[4-[6-(azetidin-1-yl)-2-methyl-1-oxo-2,7-naphthyridin-4-yl]-2,6-dimethoxyphenyl]methyl]-3-(methoxymethyl)piperazin-1-yl]ethyl]piperidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione has a molecular weight of 861.01 g/mol, XLogP of 3.67, 13 rotatable bonds, 1 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for 5-[4-[2-[4-[[4-[6-(azetidin-1-yl)-2-methyl-1-oxo-2,7-naphthyridin-4-yl]-2,6-dimethoxyphenyl]methyl]-3-(methoxymethyl)piperazin-1-yl]ethyl]piperidin-1-yl]-2-(2,6-dioxopiperidin-3-yl)isoindole-1,3-dione is sourced from PubChem (CID 167395312), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).